Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Macro

China Denies Breaking Trade Truce as U.S.-China Tensions Escalate

by Team Lumida
June 2, 2025
in Macro
Reading Time: 4 mins read
A A
0
China’s Manufacturing Powerhouse Faces Domestic Struggles: What It Means for Global Investors

"MY ROAD : FLAG OF CHINA" by Lαin is licensed under CC BY-NC-ND 2.0

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • China rejected President Trump’s accusations of violating a trade truce, claiming it upheld the Geneva consensus while accusing the U.S. of undermining the agreement with restrictive measures.
  • Tensions have flared over issues such as U.S. export controls on AI chips, visa restrictions for Chinese students, and China’s rare-earth mineral exports.
  • Trump reiterated his accusations, stating he plans to discuss the matter with Chinese President Xi Jinping.
  • The breakdown in progress toward a deal has rattled markets, with Hong Kong’s Hang Seng Index falling 2.2% and the Hang Seng Tech Index dropping 2.4%.

What Happened?

China’s Commerce Ministry pushed back against President Trump’s claims that Beijing violated a trade truce reached in mid-May during talks in Geneva. The agreement had temporarily lowered tariffs, offering a brief reprieve to global markets.

In a statement, China accused the U.S. of undermining the consensus by introducing “discriminatory and restrictive measures,” including export controls on AI chips and visa revocations for Chinese students. Trump, however, accused China of violating “a big part of the agreement” and expressed his intention to discuss the issue with Chinese President Xi Jinping.

The renewed tensions have dampened optimism for a lasting trade deal, with markets reacting negatively. Chinese stocks in Hong Kong fell sharply, led by declines in the Hang Seng Index and Hang Seng Tech Index.


Why It Matters?

The re-escalation of U.S.-China trade tensions highlights the fragility of the temporary truce and the challenges in reaching a lasting agreement. Key issues, such as technology export controls and rare-earth mineral exports, remain contentious, further complicating negotiations.

The market reaction underscores the economic stakes of the ongoing trade dispute. Declines in Chinese equities reflect investor concerns about the potential for prolonged uncertainty and its impact on global trade and economic growth.

Trump’s accusations and China’s counterclaims also signal a deepening mistrust between the two superpowers, raising questions about the feasibility of resolving broader geopolitical and economic tensions.


What’s Next?

President Trump’s planned discussion with Chinese President Xi Jinping will be closely watched for signs of progress or further escalation. Meanwhile, markets will monitor developments in U.S.-China relations, including potential retaliatory measures from Beijing.

Investors will also keep an eye on the impact of U.S. export controls and visa restrictions, as well as China’s response to Trump’s threat to double tariffs on steel and aluminum imports. The outcome of these disputes will shape the trajectory of global markets and trade dynamics in the coming months.

Source
Tags: China
Previous Post

Corporate Pension Funds Shift Strategies Amid Full Funding, Impacting Bonds and Private Equity

Next Post

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Recommended For You

Supreme Court Pauses Order for Trump Administration to Pay Full SNAP Benefits

by Team Lumida
1 day ago
Supreme Court Pauses Order for Trump Administration to Pay Full SNAP Benefits

Key Takeaways Powered by lumidawealth.com Justice Ketanji Brown Jackson issued an administrative stay, pausing a lower court’s order requiring full SNAP (food stamp) funding for November. The pause halts...

Read more

China’s Exports Unexpectedly Contract in October

by Team Lumida
2 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Exports fell 1.1% year-over-year in October, reversing September’s 8.3% increase. The result missed expectations for 2.8% growth, signaling weaker overseas demand and a high...

Read more

Supreme Court’s Skepticism on Trump Tariffs Means Uncertainty Reigns

by Team Lumida
3 days ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key Takeaways Powered by lumidawealth.com The U.S. Supreme Court signaled doubts over Trump’s use of emergency powers to impose tariffs under the International Emergency Economic Powers Act (IEEPA). Even...

Read more

U.S. to Reduce Flight Traffic by 10% at 40 Airports Because of Shutdown

by Team Lumida
3 days ago
gray airplane on parking

Key Takeaways for Travelers and Investors Powered by lumidawealth.com 10% cap at 40 airports starts Friday; up to 1,800 flights potentially curtailed day one. Disruption likely concentrated in regional/non-hub...

Read more

Low-Income Americans Sue Trump Officials to Fund Food Benefits

by Team Lumida
4 days ago
Low-Income Americans Sue Trump Officials to Fund Food Benefits

Key Takeaways Powered by lumidawealth.com Plaintiffs: SNAP recipients suing Trump officials over halted food aid. Claim: The administration must provide benefits despite the shutdown. Scope: 42 million Americans affected...

Read more

Trump’s Tariffs Face the Supreme Court: What’s at Stake

by Team Lumida
4 days ago
Trump Fires BLS Chief After Weak Jobs Report, Eyes More Fed Influence

Key TakeawaysPowered by lumidawealth.com Fiscal implications loom large as tariff revenues were tied to tax-cut offsets.The Supreme Court is set to decide whether President Donald Trump’s sweeping tariff program...

Read more

China Urges US to Avoid ‘Red Lines’ After Trade Truce

by Team Lumida
5 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways from the US-China Trade Truce Powered by lumidawealth.com China’s four red lines: Taiwan, human rights, political system, and development rights. Ambassador Xie Feng calls for “respect for...

Read more

China to Resume Exports of Key Metals to U.S. in Trade Truce

by Team Lumida
6 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways: Powered by lumidawealth.com China will restart U.S.-bound exports of gallium, germanium, and antimony. The move is part of a Trump-Xi trade truce aimed at easing tensions. Export...

Read more

Trump Warns China of “Consequences” Over Any Taiwan Attack

by Team Lumida
6 days ago
Trump Announces 25% Tariffs on Mexico and Canada, Targeting Border Security and Trade

Key Takeaways: Powered by lumidawealth.com Trump signaled deterrence toward China without committing to military intervention in Taiwan. Remarks renew focus on the U.S. policy of “strategic ambiguity.” The comments...

Read more

China’s Factory Pulse Cools: Private PMI Slips as Export Orders Contract

by Team Lumida
6 days ago
China’s Bold Economic Moves: What You Need to Know Now

Key Takeaways Powered by lumidawealth.com Private manufacturing PMI (S&P Global/RatingDog) eased to 50.6 in October (Sep: 51.2), signaling slower expansion. New export orders fell back into contraction; demand and...

Read more
Next Post
Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

Sanofi to Acquire Blueprint Medicines in $9.5 Billion Deal to Boost Immunology Portfolio

AI Investment Boom: How Tech Giants Are Leading the Charge

AI Models Show Alarming Ability to Evade Human Control, Highlighting Urgent Need for Alignment Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Chinese Bubble Tea Stocks Surge Amid Food-Delivery Platforms’ Discount War

Chinese Bubble Tea Stocks Surge Amid Food-Delivery Platforms’ Discount War

July 7, 2025
Super Micro to Expand U.S. Production as AI Demand Surges

Super Micro to Expand U.S. Production as AI Demand Surges

May 21, 2025
Amazon’s $100 Billion Bet: AI Over Retail

Amazon’s $100 Billion Bet: AI Over Retail

June 30, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018